Furthermore, the upregulation of the KMO gene in human hepatocellular carcinoma (HCC) and breast cancers is associated with a worse prognosis, as an elevated expression of KMO participates in the proliferation, migration, and invasion of tumors [15,16]. The gene discussed is KMO; the disease is hepatocellular carcinoma.